Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score28
United States Fiscal year ends December CIK 0001061983
$62.91 +1.45% Close, 9 Oct 2026
Price $62.91 +73.50% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue106.4Operating income18.7Net income16.5EPS, diluted0.39Fiscal year 2017Revenue13.4 −87.4%Operating income−113.4Net income−127.8 −876.7%EPS, diluted−2.59Fiscal year 2018Revenue31.5 +135.6%Operating income−88.9Net income−106.3Fiscal year 2019Revenue26.9 −14.7%Operating income−98.9Net income−121.7Fiscal year 2020Revenue55.8 +107.8%Operating income−93.9Net income−127.3EPS, diluted−1.97Fiscal year 2021Revenue70.4 +26.2%Operating income−186.3Net income−215.3EPS, diluted−2.80Fiscal year 2022Revenue94.6 +34.3%Operating income−324.2Net income−389.0EPS, diluted−4.33Fiscal year 2023Revenue7.5 −92.0%Operating income−496.2Net income−526.2EPS, diluted−5.45Fiscal year 2024Revenue18.5 +145.3%Operating income−536.2Net income−589.5EPS, diluted−5.26Fiscal year 2025Revenue88.0 +376.6%Operating income−612.3Net income−785.0EPS, diluted−6.54
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 106.4 13.4 31.5 26.9 55.8 70.4 94.6 7.5 18.5 88.0
Growth −87.4% +135.6% −14.7% +107.8% +26.2% +34.3% −92.0% +145.3% +376.6%
Operating income 18.7 −113.4 −88.9 −98.9 −93.9 −186.3 −324.2 −496.2 −536.2 −612.3
Net income 16.5 −127.8 −106.3 −121.7 −127.3 −215.3 −389.0 −526.2 −589.5 −785.0
Growth −876.7%
EPS, diluted 0.39 −2.59 n/a n/a −1.97 −2.80 −4.33 −5.45 −5.26 −6.54

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin17.6%Net margin15.5%Free cash flow margin33.3%Fiscal year 2017Operating margin−848.3%Net margin−955.9%Free cash flow margin−782.7%Fiscal year 2018Operating margin−282.3%Net margin−337.4%Free cash flow margin−324.1%Fiscal year 2019Operating margin−368.0%Net margin−452.9%Free cash flow margin−348.1%Fiscal year 2020Operating margin−168.3%Net margin−228.0%Free cash flow margin−3.8%Fiscal year 2021Operating margin−264.5%Net margin−305.7%Free cash flow margin−271.8%Fiscal year 2022Operating margin−342.8%Net margin−411.2%Free cash flow margin−328.6%Fiscal year 2023Operating margin−6,589.7%Net margin−6,988.6%Free cash flow margin−5,521.2%Fiscal year 2024Operating margin−2,902.7%Net margin−3,191.1%Free cash flow margin−2,164.1%Fiscal year 2025Operating margin−695.4%Net margin−891.6%Free cash flow margin−607.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 17.6% −848.3% −282.3% −368.0% −168.3% −264.5% −342.8% −6,589.7% −2,902.7% −695.4%
Net margin 15.5% −955.9% −337.4% −452.9% −228.0% −305.7% −411.2% −6,988.6% −3,191.1% −891.6%
Free cash flow margin 33.3% −782.7% −324.1% −348.1% −3.8% −271.8% −328.6% −5,521.2% −2,164.1% −607.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow37.0Capital expenditure−1.6Free cash flow35.4Fiscal year 2017Operating cash flow−101.8Capital expenditure−2.9Free cash flow−104.6 −395.7%Fiscal year 2018Operating cash flow−101.2Capital expenditure−0.9Free cash flow−102.1Fiscal year 2019Operating cash flow−90.9Capital expenditure−2.6Free cash flow−93.5Fiscal year 2020Operating cash flow8.9Capital expenditure−11.1Free cash flow−2.1Fiscal year 2021Operating cash flow−142.5Capital expenditure−48.9Free cash flow−191.4Fiscal year 2022Operating cash flow−299.5Capital expenditure−11.3Free cash flow−310.9Fiscal year 2023Operating cash flow−414.3Capital expenditure−1.4Free cash flow−415.7Fiscal year 2024Operating cash flow−395.9Capital expenditure−3.9Free cash flow−399.8Fiscal year 2025Operating cash flow−510.0Capital expenditure−24.8Free cash flow−534.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 37.0 −101.8 −101.2 −90.9 8.9 −142.5 −299.5 −414.3 −395.9 −510.0
Capital expenditure −1.6 −2.9 −0.9 −2.6 −11.1 −48.9 −11.3 −1.4 −3.9 −24.8
Free cash flow 35.4 −104.6 −102.1 −93.5 −2.1 −191.4 −310.9 −415.7 −399.8 −534.8
Growth −395.7%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash66.9Total debt29.9Net cash (debt)37.0Shareholders’ equity94.4Debt to equity0.32Fiscal year 2017Cash125.2Total debt31.8Net cash (debt)93.4Shareholders’ equity109.8Debt to equity0.29Fiscal year 2018Cash42.3Total debt42.4Net cash (debt)−0.2Shareholders’ equity25.9Debt to equity1.64Fiscal year 2019Cash36.4Total debt45.1Net cash (debt)−8.6Shareholders’ equity−10.9Fiscal year 2020Cash83.0Total debt46.2Net cash (debt)36.8Shareholders’ equity113.4Debt to equity0.41Fiscal year 2021Cash112.7Total debt47.4Net cash (debt)65.3Shareholders’ equity243.9Debt to equity0.19Fiscal year 2022Cash65.6Total debt64.8Net cash (debt)0.8Shareholders’ equity−107.9Fiscal year 2023Cash113.0Total debt68.5Net cash (debt)44.6Shareholders’ equity−386.3Fiscal year 2024Cash94.9Total debt104.7Net cash (debt)−9.9Shareholders’ equity−135.4Fiscal year 2025Cash122.5Total debt287.6Net cash (debt)−165.0Shareholders’ equity−659.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 66.9 125.2 42.3 36.4 83.0 112.7 65.6 113.0 94.9 122.5
Total debt 29.9 31.8 42.4 45.1 46.2 47.4 64.8 68.5 104.7 287.6
Net cash (debt) 37.0 93.4 −0.2 −8.6 36.8 65.3 0.8 44.6 −9.9 −165.0
Shareholders’ equity 94.4 109.8 25.9 −10.9 113.4 243.9 −107.9 −386.3 −135.4 −659.6
Debt to equity 0.32 0.29 1.64 n/a 0.41 0.19 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
66.9 125.2 42.3 36.4 83.0 112.7 65.6 113.0 94.9 122.5
0.0 1.1 2.2 5.2 4.4 51.8 0.1 1.3 16.7 17.8
n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.0
3.6 3.6 3.2 4.5 13.3 73.3 80.5 68.7 65.8 79.2
170.1 294.8 211.2 289.8 533.8 841.3 1,014.8 824.3 1,401.7 1,424.5
Growth +73.3% −28.4% +37.2% +84.2% +57.6% +20.6% −18.8% +70.0% +1.6%
Liabilities
2.5 0.0 2.6 0.0 0.0 n/a 1.0 10.1 11.5 41.2
27.4 31.8 39.8 45.1 46.2 47.4 63.8 58.4 93.2 246.4
calc 29.9 31.8 42.4 45.1 46.2 47.4 64.8 68.5 104.7 287.6
75.8 185.0 185.2 300.8 420.4 597.5 1,122.7 1,210.6 1,537.0 2,084.2
Equity
−518.3 −646.1 −743.3 −865.0 −992.3 −1,207.6 −1,586.0 −2,112.2 −2,701.8 −3,486.7
94.4 109.8 25.9 −10.9 113.4 243.9 −107.9 −386.3 −135.4 −659.6
Growth +16.4% −76.4% −142.2% +115.1% −144.2%
Per share and net cash
calc 37.0 93.4 −0.2 −8.6 36.8 65.3 0.8 44.6 −9.9 −165.0
40.6 54.0 54.7 59.2 71.0 84.8 94.8 101.6 118.2 122.9
calc 2.32 2.04 0.47 −0.18 1.60 2.88 −1.14 −3.80 −1.15 −5.37

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.